Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 15, Issue 5, 1997, Pages 381-386

  Krook, A ^a,b   Albert, J ^c   Andersson, S ^c   Biberfeld, G ^c   Blomberg, J ^d   Eklund, I ^a   Engstrom A ^a   Julander, I ^a   Kail, K ^c   Martin, C ^a   Stendahl, P ^c   Struve, J ^a   Sonnerborg A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ST GÖRAN S HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amphetamine abuse; Hepatitis A, B, C, and D epidemiology; HIV epidemiology; HTLV I epidemiology; HTLV II epidemiology; Injection debut; Opiate abuse; Risk factors for bloodborne infections

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; DELTA AGENT HEPATITIS; FEMALE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEROPREVALENCE; SWEDEN; VIRUS INFECTION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HTLV; HTLV II; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN T CELL LYMPHOTROPIC VIRUS TYPE I; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2;

EID: 12644261429     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199708150-00009     Document Type: Article

References (21)

1. Center for Disease Control and Prevention and the O.S.P.H.S. Working Group. Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II). Ann Intern Med 1993;118:448-54.
2. Lee H, Swanson P, Shorty VS, et al. High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science 1989; 244:471-5.
3. Weiss SH. The evolving epidemiology of human T lymphotropic virus type II. J Infect Dis 1994;169:1080-3.
4. Hall WW, Kubo T, Ijichi S, et al. Human T cell leukemia/ lymphoma virus, type II (HTLV-II): emergence of an important newly recognized pathogen. Semin Virol 1994;5:165-78.
5. Murphy EL. HTLV-II related disease. Lancet 1993;341:888.
6. Robert-Guroff M, Weiss SH, Giron JA, et al. Prevalence of antibodies to HTLV-I, -II and -III in intravenous drug abusers from an AIDS endemic region. JAMA 1986;255:3133-7.
7. Zella D, Mon L, Sala M. HTLV-II infection in Italian drug abusers. Lancet 1990;2:575-6.
8. Zanetti AR, Zehender G, Tanzi E, et al. HTLV-II among Italian intravenous drug users and hemophiliacs. Eur J Epidemiol 1992; 8:702-7.
9. Soriano V, Calderon E, Esparza B, et al. HTLV I/II infection in Spain. Int J Epdemiol 1993;22:716-9.
10. Vignoli C, Zandetti C, De Lamballerie X, et al. Prevalence of HTLV-II infection in HIV-I infected drug addicts in Marseille. Eur J Epidemiol 1993;9:351-2.
11. Flö RW, Holm Samdal HH, Kalland K-H, et al. Diagnosis of infection with human T-lymphotropic virus type II (HTLV-II) in Norwegian HIV-infected individuals. Clin Diagn Virol 1993;1: 143-52.
12. Blomberg J, Moestrup T, Frimand J, et al. HTLV-I and -II in intravenous drug users from Sweden and Denmark. Scand J Infect Dis 1994;26:23-6.
13. Krook A, Blomberg J. HTLV-II among injecting drug users in Stockholm. Scand J Infect Dis 1994;26:129-32.
14. Andersson S, Krook A, Käil K, et al. HTLV infections among Swedish intravenous drug users in 1992. Scand J Infect Dis 1995; 27:547-550.
15. Schwebke J, Calsyn D, Shiver K, et al. Prevalence and epidemiologic correlates of human T-cell lymphotropic virus infection among intravenous drug users. J Infect Dis 1994;169:962-7.
16. Feigal E, Murphy E, Vranizan K, et al. Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: Risk Factors Associated with seropositivity. J Infect Dis 1991;164: 36-42.
17. Biggar RJ, Buskell-Bales Z, Yakshe PN, et al. Antibody to human retroviruses among drug users in three east coast American cities, 1972-1976. J Infect Dis 1991;163:57-63.
18. Khabbaz RF, Hartel D, Lairmore M, et al. Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection? J Infect Dis 1991;163:252-6.
19. Kali KI, Olin R. HIV status and changes in risk behaviour among intravenous drug users in Stockholm 1987-1988. AIDS 1990;4: 153-7.
20. Albert J, Fenyö EM. Simple, sensitive and specific detection of HIV-I in clinical specimens by polymerase chain reaction with nested primers. J Clin Microbiol 1990;28:1560-4.
21. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237-8.